Yüklüyor......
TLR AGONISTS: Are They Good Adjuvants?
Therapeutic immunization leading to cancer regression remains a significant challenge. Successful immunization requires activation of adaptive immunity, including tumor specific CD4 + T cells and CD8+ T cells. Generally speaking, the activation of T cells is compromised in patients with cancer due t...
Kaydedildi:
| Asıl Yazarlar: | , , |
|---|---|
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
2010
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2922045/ https://ncbi.nlm.nih.gov/pubmed/20693851 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1097/PPO.0b013e3181eaca65 |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|